CASP3 and neoplasm: Immunohistochemical analysis shows Compound A to increase levels of cleaved caspase-3 and decrease the levels of the proliferation marker, PCNA compared to the control tumors (Fig. 9c), suggesting that this treatment is able to effectively induce apoptosis and reduce cell proliferation in the tumor tissue.